Join the DDA or

Emerade recall

No further supplies anticipated

December 2nd 2019

Tagged: MHRA alert

By MHRA

Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade due to an error in one component of the autoinjector believed to cause some pens to fail to activate and deliver adrenaline.
Patients do not need to return Emerade stock already in their possession but they should be informed of the updated safety information in this alert.
No further supplies of Emerade will be available on the UK market until the issue has been resolved, therefore patients and carers should be appropriately trained to use other brands.

 

For all the latest news of the 2019 DDA annual conference...

Learn more